IMV Announces Final Topline Results of the DeCidE1 Clinical Trial in Advanced Recurrent Ovarian Cancer | Business Wire
Deconstructing all types of monitoring visits
Clinical Trials :: IMV Inc. (IMV)
Common Clinical Trial Acronyms and Abbreviations - MPN Cancer Connection
Failing Safely: Why Ending Some Programmes Early May Be a Recipe for Successes Later
Tool Summary Sheet: Clinical Monitoring Plan Template
IMV Inc. Announces Fourth Quarter and Full Year 2020 Financial and Operational Results
Q&A: Why IMV's DPX-Survivac shows promise in treating ovarian cancer - Drug Discovery and Development
Guidance For Remote Monitoring or Auditing in Clinical Research
Everything You Ever Wanted To Know About Interim Monitoring Visits | by Dan Sfera | Medium
IMV Inc. Announces Q3 2018 Financial Results and Investor Conference Call Details
IMV – Course Shelves
Exhibit 99.2
Initial Phase 2 Data From an IMV Clinical Study Continues to Demonstrate DPX-Survivac's Prior Trend as a Potential Monotherapy Treatment for Advanced Ovarian Cancer | Clearity Foundation
IMV Released Final Topline Results for Its DeCidE1 Clinical Trial | Science Times
Clinical Pipeline :: IMV Inc. (IMV)
Clinical Research Monitoring 101: The Basics You Need To Understand To Become A Clinical Research Associate | by Dan Sfera | Medium
DPX-Survivac | IMV
A Real IMV with the CRA Academy Interns and meeting with their PI and Clinical Research Coordinator - YouTube
IMV announces the first wave of 2022 IMV ServiceTrak™ Clinical Laboratory Awardees at AACC 2022 - IMV Medical Information Division
Preparing for and Handling Monitoring Visits and Audits
IMV Inc. on Twitter: "Today we announced that the first patient has been dosed in our VITALIZE Phase 2B clinical study in partnership with @Merck for patients with relapsed/refractory diffuse large B
Management's Report on Financial Position and Operating Results
